Outstanding Shares 99,478,052 a/o Oct 31, 2016
L2 Available here: http://www.otcmarkets.com/stock/PSID/quote
(((( BREAKING NEWS ))))
PSID will be here NOV 29-DEC 2 http://www.amsusmeetings.org/keynote-plenary-speakers/#Wednesday
Exibiting this http://www.psidcorp.com/system/files/media/Zika%20White%20Paper%20Final.pdf
"Under this Phase II award, PositiveID will provide its Firefly Dx system, designed to be a fully automated, lab quality, real-time device able to detect bio-threats at the point of need in minutes instead of hours."
THE FIREFLY DX IS REAL!!!
PAID PROMOTIONS MAY BE MANIPULATING PSID STOCK
FOX News TV interview October 2014 http://video.foxbusiness.com/v/3841659343001/the-latest-technology-to-test-for-ebola/?#sp=show-clips
BioPrepWatch article June 9 2015 Positive ID's Firefly Dx http://bioprepwatch.com/stories/510548516-positiveid-s-handheld-device-makes-rapid-biological-testing-user-friendly
SmallCapVoice interview April 2013 17 minutes long https://www.youtube.com/watch?v=H1rWoXuYj6M
Boeing Corp has entered into a licensing agreement to manufacture and sell M-Band
PositiveID Corporation Enters Into License Agreement and Teaming Agreement With The Boeing Company / BA
PositiveID Provides Boeing an Exclusive License to Manufacture and Sell M-BAND Units for the North American Market; PositiveID Retains Exclusive Rights to be the Reagent and Assay Supplier for the M-BAND Systems The Boeing Company ("Boeing"), including a license fee to PositiveID of $2.5 million.
The license agreement provides Boeing the exclusive license to manufacture and sell PositiveID's M-BAND (Microfluidics-based Bioagent Networked Detector) airborne bio-threat detector for the U.S. Department of Homeland Security's ("DHS") BioWatch Generation 3 opportunity, as well as other opportunities (government or commercial) that may arise in the North American market. Under the teaming agreement, PositiveID will retain exclusive rights to serve as the reagent and assay supplier of the M-BAND systems to Boeing in the U.S. market. PositiveID will also retain the right to sell M-BAND units, reagents and assays in international markets.
PositiveID's M-BAND, developed under contract for DHS Science and Technology Division, is a bioaerosol monitor with fully integrated systems with sample collection, processing and detection modules that continuously analyze air samples for the detection of bacteria, viruses, and toxins. Results from individual M-BAND instruments are reported via a secure wireless network in real time to give an accurate and up to date status for fielded instruments in the aggregate.
November 16, 2016 PositiveID Corporation Publishes White Paper and Data on its Successful Detection of Zika Virus
1690 South Congress Avenue
Delray Beach, FL 33445
Innovative Health Solutions
PositiveID's innovative and advanced healthcare and medical solutions, developed from its expanding intellectual property portfolio, are designed to address unmet needs in the market. From non-invasive blood glucose monitoring through the creation of novel sensing devices, to rapid and precise biological detection at the point-of-care, PositiveID provides tools and technologies for a better quality of life. PositiveID operates in two main divisions, HealthID and ID Security. For more information on PositiveID, please visit www.PositiveIDCorp.com.
PAID PROMOTIONS MAY BE MANIPULATING PSID STOCK ^